Shyh‐Ming Yang

1.7k total citations
41 papers, 1.2k citations indexed

About

Shyh‐Ming Yang is a scholar working on Molecular Biology, Organic Chemistry and Materials Chemistry. According to data from OpenAlex, Shyh‐Ming Yang has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Organic Chemistry and 9 papers in Materials Chemistry. Recurrent topics in Shyh‐Ming Yang's work include Photonic Crystals and Applications (6 papers), Protein Degradation and Inhibitors (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Shyh‐Ming Yang is often cited by papers focused on Photonic Crystals and Applications (6 papers), Protein Degradation and Inhibitors (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Shyh‐Ming Yang collaborates with scholars based in United States, Taiwan and South Korea. Shyh‐Ming Yang's co-authors include Gi‐Ra Yi, David J. Pine, Jun Hyuk Moon, Jim‐Min Fang, Vinothan Manoharan, Sewon Park, Younghoon Kim, Mark T. Elsesser, Eric Michel and David J. Maloney and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and PLoS ONE.

In The Last Decade

Shyh‐Ming Yang

39 papers receiving 1.2k citations

Peers

Shyh‐Ming Yang
Wen‐Ji Dong United States
Taehyung Kim South Korea
Rafał Fudala United States
Lorenzo Brancaleon United States
Xiao Peng China
Shyh‐Ming Yang
Citations per year, relative to Shyh‐Ming Yang Shyh‐Ming Yang (= 1×) peers Satoshi Sakamoto

Countries citing papers authored by Shyh‐Ming Yang

Since Specialization
Citations

This map shows the geographic impact of Shyh‐Ming Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shyh‐Ming Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shyh‐Ming Yang more than expected).

Fields of papers citing papers by Shyh‐Ming Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shyh‐Ming Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shyh‐Ming Yang. The network helps show where Shyh‐Ming Yang may publish in the future.

Co-authorship network of co-authors of Shyh‐Ming Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shyh‐Ming Yang. A scholar is included among the top collaborators of Shyh‐Ming Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shyh‐Ming Yang. Shyh‐Ming Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasgar, Adam, Sankalp Jain, Marissa A. Davies, et al.. (2025). Integrated Approach of Machine Learning and High-Throughput Screening to Identify Chemical Probe Candidates Targeting Aldehyde Dehydrogenases. ACS Pharmacology & Translational Science. 8(10). 3568–3584.
2.
Yu, Pengfei, Shuwen Cao, Shyh‐Ming Yang, et al.. (2023). RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma. Cancer Immunology Research. 12(2). 180–194. 2 indexed citations
3.
Banerjee, Ananya, Na Li, Shurui Cai, et al.. (2023). ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expression. npj Precision Oncology. 7(1). 66–66. 13 indexed citations
4.
Michael, Sam, Shyh‐Ming Yang, Ruili Huang, et al.. (2022). Retro Drug Design: From Target Properties to Molecular Structures. Journal of Chemical Information and Modeling. 62(11). 2659–2669. 10 indexed citations
5.
Zakharov, Alexey, Sukumar Sarkar, Shyh‐Ming Yang, et al.. (2021). A Genome-Edited ERα-HiBiT Fusion Reporter Cell Line for the Identification of ERα Modulators Via High-Throughput Screening and CETSA. Assay and Drug Development Technologies. 19(8). 539–549. 4 indexed citations
6.
Yoshioka, Makoto, Kuniaki Tanaka, Shyh‐Ming Yang, et al.. (2021). CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia. Biochemical and Biophysical Research Communications. 590. 49–54. 11 indexed citations
7.
Park, Sun-Ji, Yeawon Kim, Shyh‐Ming Yang, et al.. (2019). Discovery of endoplasmic reticulum calcium stabilizers to rescue ER-stressed podocytes in nephrotic syndrome. Proceedings of the National Academy of Sciences. 116(28). 14154–14163. 48 indexed citations
8.
Yang, Shyh‐Ming, Makoto Yoshioka, Jeffrey Strovel, et al.. (2019). Lead optimization and efficacy evaluation of quinazoline-based BET family inhibitors for potential treatment of cancer and inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 29(10). 1220–1226. 10 indexed citations
9.
Manthei, Kelly A., Shyh‐Ming Yang, Bolormaa Baljinnyam, et al.. (2018). Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol. eLife. 7. 31 indexed citations
10.
Yang, Shyh‐Ming, Daniel J. Urban, Makoto Yoshioka, et al.. (2018). Discovery and lead identification of quinazoline-based BRD4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(21). 3483–3488. 13 indexed citations
11.
Martinez, Natalia J., Alexey Zakharov, Daniel J. Urban, et al.. (2018). A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase. Scientific Reports. 8(1). 9472–9472. 63 indexed citations
12.
Yang, Shyh‐Ming, Natalia J. Martinez, Adam Yasgar, et al.. (2018). Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity. Journal of Medicinal Chemistry. 61(11). 4883–4903. 70 indexed citations
13.
Srivastava, Amit Kumar, Chunhua Han, Dayong Wu, et al.. (2018). DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1. Cell Death and Disease. 9(5). 561–561. 33 indexed citations
14.
Yasgar, Adam, Steven A. Titus, Yuhong Wang, et al.. (2017). A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity. PLoS ONE. 12(1). e0170937–e0170937. 31 indexed citations
15.
Yang, Shyh‐Ming, Adam Yasgar, Bettina Miller, et al.. (2015). Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1). Journal of Medicinal Chemistry. 58(15). 5967–5978. 61 indexed citations
16.
Yang, Shyh‐Ming, Yuting Tang, Thomas A. Rano, et al.. (2014). 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: Part 2. Pyridazine-based analogs. Bioorganic & Medicinal Chemistry Letters. 24(5). 1437–1441. 6 indexed citations
17.
Yang, Shyh‐Ming, Yuting Tang, Rui Zhang, et al.. (2013). 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: Urea-based analogs. Bioorganic & Medicinal Chemistry Letters. 23(24). 6773–6776. 5 indexed citations
18.
Choi, Dae‐Geun, et al.. (2005). Multifaceted and Nanobored Particle Arrays Sculpted Using Colloidal Lithography. Advanced Functional Materials. 16(1). 33–40. 33 indexed citations
19.
Babu, G. Suresh, Hui‐Ming Yu, Shyh‐Ming Yang, & Jim‐Min Fang. (2004). Carbazolothiophene-2-carboxylic acid derivatives as endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(5). 1129–1132. 10 indexed citations
20.
Babu, G. Suresh, Hui‐Ming Yu, Shyh‐Ming Yang, & Jim‐Min Fang. (2004). Carbazolothiophene‐2‐carboxylic Acid Derivatives as Endothelin Receptor Antagonists.. ChemInform. 35(25). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026